Show simple item record

dc.contributor.authorRujas Díez, Edurne
dc.contributor.authorLeaman, Daniel P.
dc.contributor.authorInsausti González, Sara
dc.contributor.authorCarravilla Palomanes, Pablo ORCID
dc.contributor.authorGarcía Porras, Miguel
dc.contributor.authorLargo Pereda, Eneko
dc.contributor.authorMorillo Melero, Izaskun
dc.contributor.authorSánchez Eugenia, Rubén ORCID
dc.contributor.authorZhang, Lei
dc.contributor.authorCui, Hong
dc.contributor.authorIloro, Ibon
dc.contributor.authorElortza, Felix
dc.contributor.authorJulien, Jean-Philippe
dc.contributor.authorEggeling, Christian
dc.contributor.authorZwick, Michael B.
dc.contributor.authorCaaveiro, Jose M.M.
dc.contributor.authorNieva Escandón, José Luis
dc.date.accessioned2021-10-25T07:39:37Z
dc.date.available2021-10-25T07:39:37Z
dc.date.issued2021-09-24
dc.identifier.citationiScience 24(9) : (2021) // Article ID 102987es_ES
dc.identifier.issn2589-0042
dc.identifier.urihttp://hdl.handle.net/10810/53612
dc.description.abstractBroadly neutralizing antibodies (bnAbs) against HIV-1 are frequently associated with the presence of autoreactivity/polyreactivity, a property that can limit their use as therapeutic agents. The bnAb 4E10, targeting the conserved Membrane proximal external region (MPER) of HIV-1, displays almost pan-neutralizing activity across globally circulating HIV-1 strains but exhibits nonspecific off-target interactions with lipid membranes. The hydrophobic apex of the third complementarity-determining region of the heavy chain (CDRH3) loop, which is essential for viral neutralization, critically contributes to this detrimental effect. Here, we have replaced the aromatic/hydrophobic residues from the apex of the CDRH3 of 4E10 with a single aromatic molecule through chemical modification to generate a variant that preserves the neutralization potency and breadth of 4E10 but with reduced autoreactivity. Collectively, our study suggests that the localized accumulation of aromaticity by chemical modification provides a pathway to ameliorate the adverse effects triggered by the CDRH3 of anti-HIV-1 MPER bnAbs.es_ES
dc.description.sponsorshipThis study was supported by the following Grants: European Commission (790012 SI H2020-MSCA-IF-2017) (E.R.); US NIAID, NIH grant R01 AI143563 (M.B. Z.); James B. Pendleton Charitable Trust (M.B.Z.); JSPS grant 20H03228 (J. M.M.C.); Spanish MCIU (RTI2018-095624-B-C21; MCIU/AEI/FEDER, UE) (J.L.N.), Basque Government (IT1196-19) (J.L.N.). C.E. acknowledges funding from Medical Research Council (grant number MC_UU_12010/unit programs G0902418 and MC_UU_12025), Wolfson Foundation, Deutsche Forschungsgemeinschaft (Excellence Cluster Balance of the Microverse, Collaborative Research Center 1278 Polytarget), Leibniz Association (Leibniz Campus Infectooptics), Wellcome Institutional Strategic Support Fund, Oxford internal funds (EPA Cephalosporin Fund and John Fell Fund), and support from the Micron Oxford Advanced Bioimaging Unit (Wellcome Trust funding 107457/Z/15/Z). This work was also supported by the Platform Project for Supporting Drug Discovery and Life Science Research [Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)] from AMED (JP21am0101091). S.I. received a predoctoral fellowship from the BasqueGovernment. P.C. would like to acknowledge the University of the Basque Country (DOCREC18/01), the Basque Government (POS_2018_1_0066) and the European Commission (H2020-MSCA-IF-2019-ST project 892232 FILM-HIV) for funding his position. This research was also supported by the CIFAR Azrieli Global Scholar program (J-P.J.), the Ontario Early Researcher Awards program (J-P.J.), and the Canada Research Chairs program (J-P.J.). Part of the biophysical data presented in this manuscript were collected at the Hospital for Sick Children Structural & Biophysical Core facility supported by the Canada Foundation for Innovation and Ontario Research Fund.es_ES
dc.language.isoenges_ES
dc.publisherCell Presses_ES
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/892232es_ES
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/790012es_ES
dc.relationinfo:eu-repo/grantAgreement/MICINN/RTI2018-095624-B-C21es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.titleFocal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profilees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderThis is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0)es_ES
dc.rights.holderAtribución-NoComercial-SinDerivadas 3.0 España*
dc.relation.publisherversionhttps://www-sciencedirect-com.ehu.idm.oclc.org/science/article/pii/S258900422100955X?via%3Dihub#!es_ES
dc.identifier.doi10.1016/j.isci.2021.102987
dc.contributor.funderEuropean Commission
dc.departamentoesBioquímica y biología moleculares_ES
dc.departamentoesInmunología, microbiología y parasitologíaes_ES
dc.departamentoeuBiokimika eta biologia molekularraes_ES
dc.departamentoeuImmunologia, mikrobiologia eta parasitologiaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0)
Except where otherwise noted, this item's license is described as This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0)